ReviewClinical parkinsonism & related disorders2023

Dopamine agonists in Parkinson's disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment.

Stuart H Isaacson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.